The crystal structure of human CD1d with and without α-galactosylceramide

Nature Immunology

Volumn 6, Issue 8, 2005, Pages 819-826

  Koch, Michael ^a   Stronge, Victoria S ^b   Shepherd, Dawn ^b   Gadola, Stephan D ^c   Mathew, Bini ^d   Ritter, Gerd ^e   Fersht, Alan R ^f   Besra, Gurdyal S ^g   Schmidt, Richard R ^d   Jones, E Yvonne ^a   Cerundolo, Vincenzo ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GLYCOLIPID; LIPID; SPHINGOSINE; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN; CD1 ANTIGEN; GALACTOSYLCERAMIDE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; ANIMAL; ANTIGEN PRESENTATION; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; IMMUNOLOGY; NATURAL KILLER CELL; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD1; CRYSTALLOGRAPHY, X-RAY; GALACTOSYLCERAMIDES; GLYCOLIPIDS; HUMANS; KILLER CELLS, NATURAL; LIPIDS; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SPHINGOSINE; T-LYMPHOCYTES;

EID: 23944479797     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1225     Document Type: Article

References (57)

1. Porcelli, S.A. & Modlin, R.L. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329 (1999).
2. Bendelac, A., Rivera, M.N., Park, S.H. & Roark, J.H. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 15, 535-562 (1997).
3. Calabi, F., Jarvis, J.M., Martin, L. & Milstein, C. Two classes of CD1 genes. Eur. J. Immunol. 19, 285-292 (1989).
4. + T cells. Nature 372, 691-694 (1994).
5. Sieling, P.A. et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
6. Moody, D.B. et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283-286 (1997).
7. Moody, D.B. et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888 (2000).
8. Naidenko, O.V., Koezuka, Y. & Kronenberg, M. CD1-mediated antigen presentation of glycosphingolipids. Microbes Infect. 2, 621-631 (2000).
9. Gilleron, M. et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199, 649-659 (2004).
10. Shamshiev, A. et al. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29, 1667-1675 (1999).
11. Shamshiev, A. et al. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195, 1013-1021 (2002).
12. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
13. Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M. & Chapman, P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003).
14. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
15. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
16. Moody, D.B. & Porcelli, S.A. Intracellular pathways of CD1 antigen presentation. Nat. Rev. Immunol. 3, 11-22 (2003).
17. Zeng, Z. et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345 (1997).
18. Gadola, S.D. et al. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3, 721-726 (2002).
19. Batuwangala, T. et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172, 2382-2388 (2004).
20. Zajonc, D.M., Elsliger, M.A., Teyton, L. & Wilson, I.A. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å. Nat. Immunol. 4, 808-815 (2003).
21. Zajonc, D.M. et al. Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22, 209-219 (2005).
22. Lawton, A.P. & Kronenberg, M. The third way: Progress on pathways of antigen processing and presentation by CD1. Immunol. Cell Biol. 82, 295-306 (2004).
23. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
24. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
25. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
26. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568 (2002).
27. Godfrey, D.I. & Kronenberg, M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388 (2004).
28. Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531-534 (2001).
29. Oki, S., Chiba, A., Yamamura, T. & Miyake, S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113, 1631-1640 (2004).
30. Yu, K.O. et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 102, 3383-3388 (2005).
31. Karadimitris, A. et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98, 3294-3298 (2001).
32. Stanic, A.K. et al. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor. J. Immunol. 171, 4539-4551 (2003).
33. α14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. USA 101, 12254-12259 (2004).
34. Wu, D. et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA 102, 1351-1356 (2005).
35. Brossay, L. et al. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 161, 5124-5128 (1998).
36. Burdin, N. et al. Structural requirements for antigen presentation by mouse CD1. Proc. Natl. Acad. Sci. USA 97, 10156-10161 (2000).
37. Sidobre, S. et al. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169, 1340-1348 (2002).
38. Brossay, L. et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521-1528 (1998).
39. Altamirano, M.M. et al. Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98, 3288-3293 (2001).
40. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997).
41. Ortaldo, J.R. et al. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol. 172, 943-953 (2004).
42. Parekh, V.V. et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids. J. Immunol. 173, 3693-3706 (2004).
43. Naidenko, O.V. et al. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190, 1069-1080 (1999).
44. Schmieg, J., Yang, G., Franck, R.W. & Tsuji, M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198, 1631-1641 (2003).
45. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004).
46. Springer, S., Doring, K., Skipper, J.C., Townsend, A.R. & Cerundolo, V. Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. Biochemistry 37, 3001-3012 (1998).
47. Kang, S.J. & Cresswell, P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5, 175-181 (2004).
48. Zhou, D. et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527 (2004).
49. Spada, F.M., Koezuka, Y. & Porcelli, S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529-1534 (1998).
50. + T cell selection and maturation by cathepsin S. Immunity 15, 909-919 (2001).
51. Chiu, Y.H. et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3, 55-60 (2002).
52. Fujii, S., Liu, K., Smith, C., Bonito, A.J. & Steinman, R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618 (2004).
53. Silk, J.D. et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest 114, 1800-1811 (2004).
54. Figueroa-Perez, S. & Schmidt, R.R. Total synthesis of α-galactosyl cerebroside. Carbohydr. Res. 328, 95-102 (2000).
55. Walter, T.S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J. Appl. Crystallogr. 36, 308-314 (2003).
56. He, X.L. et al. Structural snapshot of aberrant antigen presentation linked to autoimmunity: The immunodommant epitope of MBP complexed with I-Au. Immunity 17, 83-94 (2002).
57. Diederichs, K. & Karplus, P.A. Improved R-factors for diffraction data analysis in macromolecular crystallography. Nat. Struct. Biol. 4, 269-275 (1997).